Janeen A. Skutnik-Wilkinson ICH Topic co-creator EWG Team Member
|
|
- Marilynn Lawrence
- 6 years ago
- Views:
Transcription
1 Janeen A. Skutnik-Wilkinson ICH Topic co-creator EWG Team Member April
2 Metal Impurities (aka Heavy Metals) STUCK for at least 10 years No Harmonised guidance in ICH or other regions Establish appropriate controls for those metals with clearly established toxicological concerns. These metal impurities may arise from the drug substances, excipients, or manufacturing processes used for drug products, may include catalysts, reagents, ligands, heavy metals or other residual metals, such as those due to the material source (e.g. Pb, Hg, As, Cd). 2
3 Approved in 2009 by ICH SC EWG created in Spring 2010 Scope restricted to criteria and limits Methodology purview of Compendia Representatives Equal mix of Safety/Toxicologists and Quality Personnel US: FDA & PhRMA EU: EMA & EFPIA Japan: MHLW/PMDA & JPMA Interested Parties IPEC, WSMI, IGPA, KFDA, BIO, WHO 3
4 Limits to be set based on published safety and toxicology data Detailed Safety & Toxicological Assessments have been done on each of the metals of interest Each will have its own report including references to the appropriate studies Build upon EU Metal Catalysts guide Excipients within scope 4
5 Determining how we are impacted? Since it is the finished dosage form that is required to comply BUT.. Testing every dosage form is not feasible Data not yet available for all components Test methods are still unclear How do we get the data we need? Need a layered approach to looking at dosage forms and components 5
6 6
7 Materials which use mined-excipients Since many elemental impurities are naturally present (for example Lead) in mined-excipients and cannot be further processed out, it is important to understand the actual levels present May have finished product which contain multiple mined excipients 7
8 Max Concentration iexisting Specifications for some commonly used grades mg e a Lead, ppm Cadmium, ppm Arsenic, ppm Mercury, ppm Aluminum silicate 94 Aluminum stearate 105 Calcium carbonate Calcium silicate Calcium stearate 91.9 Calcium sulfate 443 Colloidal silicon dioxide Potassium phosphate, dibasic 30 Sodium phosphate, dibasic, anhydrous 300 Sodium phosphate, dibasic, heptahydrate 500 Anhydrous Dibasic calcium phosphate Dibasic calcium phosphate, dihydrate Dihydroxyaluminum sodium carbonate 1350 Magnesium aluminum silicate hydrate 60 Magnesium carbonate 250 Magnesium hydroxide 450 Magnesium oxide 63 Magnesium stearate Magnesium sulfate 29.8 Magnesium trisilicate Talc Titanium dioxide Tribasic calcium phosphate
9 Please note especially the two highlighted per dose levels TiO2 is used in some approved drug products at very high levels and actual typical levels of 1 to 9 ppm for lead have been seen in actual routine commercial batches. This may cause some issues if the lead PDE will be < 5 ug per day. Lead from TiO2 per dose, based on 10 ppm spec 1387 mg x 10 ug/1000 mg = ug <---- One dose could be 2 1/2 times higher than the 5 ug per day PDE. This only takes into consideration Pb from one excipient other excipients in the formulation could also contribute.. What if there are multiple doses prescribed? Even if the lead level in the TiO2 was only 5 ppm which is very typical of actual commercial material, the 5 ug PDE would still be exceeded by one dose. 9
10 Bottom line Finished dosage forms will need to comply New products Eventually will apply to existing Added complication that existing components are not grandfathered 10
11 Some thoughts Analyze products in development / on market focusing on materials with highest risk of having metals Products using mined-excipients (for example) Be prepared to review ICH Step 2 document to provide information, data and concerns Actual data to substantiate concerns will be needed 11
12 Preliminary comments from constituents have been collected and sent back to the ICH EWG EWR still has a goal to reach Step 2 in June
13 An opportunity. Sharing of information / data Addressing challenges Raising awareness Share concerns and brainstorm solutions Outcomes Will be consolidated and shared with ICH EWG 13
14 Share viewpoints openly and candidly Take information back to your company, colleagues and contacts Provide your comments, concerns and suggestions 14
15 Q&A NJPQCA - January
Converting between PDEs and Concentration Limits
Module 7 Converting between PDEs and Concentration Limits ICH Q3D Elemental Impurities Disclaimer: This presentation includes the authors views on Elemental Impurities theory and practice. The presentation
More informationActual Excipient Test Data on Metal Impurities Submitted to IPEC-Americas from Industry
Actual Excipient Test Data on Metal Impurities Submitted to IPEC-Americas from Industry Priscilla Zawislak Chair Compendial Review Committee IPEC Americas Global Regulatory Affairs Manager Ashland Inc.
More informationManufacturer of High Purity Chemicals PRODUCT LIST
Manufacturer of High Purity Chemicals PRODUCT LIST Ammonium NH4 Ammonium Jost Chemical Co. manufactures a range of high purity ammonium phosphates, sulfates and citrates. Ammonium phosphates can be used
More informationU.S. Requirements for Dietary Supplement Ingredients and USP <2232> Elemental Impurities Is Your Company Ready for Implementation?
U.S. Requirements for Dietary Supplement Ingredients and USP Elemental Impurities Is Your Company Ready for Implementation? Priscilla Zawislak NIA-West, Ojai, CA May 28, 2015 1 Outline Ø U.S. Regulatory
More informationElement Specific Chapters. Kahkashan Zaidi, Ph.D. Principal Scientific Liaison
Element Specific Chapters Kahkashan Zaidi, Ph.D. Principal Scientific Liaison Element Specific Chapters Arsenic 211 Lead 251 Selenium 291 Mercury 261 2 Other Element Specific chapters in the USP-NF Stim
More informationGeneral Chapter/Section: <232> Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No.
General Chapter/Section: Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No. of Commenters: 18 Editorial changes suggested by commenters have been reviewed by
More informationMANUFACTURER OF HIGH PURITY SPECIALTY CHEMICALS
The IPEC Excipient Stability Program Guide 2010 MANUFACTURER OF HIGH PURITY SPECIALTY CHEMICALS For the, nutraceutical, pharmaceutical, food & other specialty markets 1 Jost Chemical Founded by Jerry Jost
More informationICH M4E(R2): Revised Guideline on Common Technical Document -- Efficacy
ICH M4E(R2): Revised Guideline on Common Technical Document -- Efficacy International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use 1 Background Regulatory authorities
More informationFormulation stability studies. 9.1 OBJECTIVE To monitor the stability of the developed herbal formulations using the limited and specific methods.
9.1 OBJECTIVE To monitor the stability of the developed herbal formulations using the limited and specific methods. 9.2 INTRODUCTION The legal definition of stability is aimed at assuring that the drug
More informationPublic Assessment Report Scientific discussion
Public Assessment Report Scientific discussion Helaflex, film-coated tablet (Harpagophytum procumbens (Burch) DC (devil s claw) dried root, dry extract (4.4-5.0:1) ethanol 60 %) SE/H/1561/01/MR This module
More informationExpectations for Implementation in Europe
Expectations for Implementation in Europe Henk de Jong IPEC Federation Observer Q3D EWG PQRI/USP Workshop 3/31 & 4/1 2015 ICH Q3D is here CHMP (committee for Medicinal Products for Human Use) approved
More informationExcipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015
Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015 Dr. Susanne Keitel Director EDQM, Council of Europe Outline 1. The European Pharmacopoeia 2. The importance of
More informationEtat des travaux du GDP
Etat des travaux du GDP (Avril 2018) Item General methods relevant to Q6A Dissolution (rev. 3) 4 Disintegration (rev. 1) 4 Uniformity of content/mass (rev. 2, corr. 1) 4 Tests for specified microorganisms
More informationגדות תעשיות ביוכימיה בע"מ Gadot Biochemical Industries Ltd.
Description: Tri Sodium Citrate Dihydrate is a white crystalline product. General Characteristics: Formula: C 6 H 5 Na 3 O. 7 2H 2 O Molecular weight: 294.11 Appearance: White crystals Taste: Saline taste
More informationPublic Assessment Report. Scientific discussion. Levofloxacin Bluefish (levofloxacin hemihydrate) SE/H/889/01-02/DC
Public Assessment Report Scientific discussion Levofloxacin Bluefish (levofloxacin hemihydrate) SE/H/889/01-02/DC This module reflects the scientific discussion for the approval of Levofloxacin Bluefish.
More informationPublic Assessment Report Scientific discussion. Oxikodon Actavis (oxycodone hydrochloride) SE/H/1226/01-03/DC
Public Assessment Report Scientific discussion Oxikodon Actavis (oxycodone hydrochloride) SE/H/1226/01-03/DC Applicant: Actavis Group PTC ehf., Iceland This module reflects the scientific discussion for
More informationEffect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs
Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs James E. Polli jpolli@rx.umaryland.edu April 26, 2016 Topics BCS Class 3 excipient study
More informationAbacavir (as sulfate) 300 mg tablets WHOPAR part 6 May 2016 (Hetero Labs Ltd), HA575
This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1
More informationCODEX STANDARD FOR MILK POWDERS AND CREAM POWDER 1 CODEX STAN
CODEX STAN 207 Page 1 of 5 CODEX STANDARD FOR MILK POWDERS AND CREAM POWDER 1 CODEX STAN 207-1999 The Annex to this Standard contains provisions which are not intended to be applied within the meaning
More informationגדות תעשיות ביוכימיה בע"מ Gadot Biochemical Industries Ltd.
Description: Tri Sodium Citrate Anhydrous is a white to off-white free-flowing product. General Characteristics: Formula: C 6 H 5 Na 3 O 7 Molecular weight: 258.08 Appearance: White to off-white granules
More informationPublic Assessment Report. Scientific discussion. Risperidon Medartuum film-coated tablets Risperidone SE/H/722/01-06/MR
Public Assessment Report Scientific discussion Risperidon Medartuum film-coated tablets Risperidone SE/H/722/01-06/MR This module reflects the scientific discussion for the approval of Risperidon Medartuum
More informationPublic Assessment Report Scientific discussion
Public Assessment Report Scientific discussion Harpatinum, capsule, soft Harpagophytum procumbens D.C. / H. zeyheri Decne (Devil s claw), radix, dry extract (4.4-5.0:1), ethanol 60 % (V/V) SE/H/1640/01/DC
More informationPublic Assessment Report Scientific discussion. Sumatriptan Pfizer (sumatriptan succinate) SE/H/973/01-02/DC
Public Assessment Report Scientific discussion Sumatriptan Pfizer (sumatriptan succinate) SE/H/973/01-02/DC This module reflects the scientific discussion for the approval of Sumatriptan Pfizer. The procedure
More informationTrace Minerals Quality Challenges
Trace Minerals Quality Challenges and Protecting our Business Tara Jarman Alltech Asia-Pacific Quality Assurance Manager Asia-Pacific Biosciences Centre Thailand Why is Quality Important? Because 80% of
More informationSCIENTIFIC DISCUSSION. Darunavir
This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1
More informationPublic Assessment Report Scientific discussion. Ciprofloxacin Pfizer (Ciprofloxacin hydrochloride) SE/H/803/01-03/DC
Public Assessment Report Scientific discussion Ciprofloxacin Pfizer (Ciprofloxacin hydrochloride) SE/H/803/01-03/DC This module reflects the scientific discussion for the approval of Ciprofloxacin Pfizer.
More informationPublic Assessment Report Scientific discussion. Oxikodon Depot Actavis (oxycodone hydrochloride) SE/H/1313/01-08/DC
Public Assessment Report Scientific discussion Oxikodon Depot Actavis (oxycodone hydrochloride) SE/H/1313/01-08/DC This module reflects the scientific discussion for the approval of Oxikodon Depot Actavis.
More informationCiprofloxacin Bluefish (Ciprofloxacin hydrochloride)
Public Assessment Report Scientific discussion Ciprofloxacin Bluefish (Ciprofloxacin hydrochloride) Asp. no: 2006-1626 - 1628 This module reflects the scientific discussion for the approval of Ciprofloxacin
More informationUSP Perspective on Atypical Actives November 29, 2017
USP Perspective on Atypical Actives November 29, 2017 USP Excipients Stakeholder Forum USP Perspective on Atypical Actives Catherine Sheehan, M.S., M.S. Senior Director, Science Excipients Outline Role
More informationPublic Assessment Report. Scientific discussion. Tevaltan comp. Film-coated tablets 80 mg/12.5 mg and 160 mg/25 mg. Valsartan and hydrochlorothiazide
Public Assessment Report Scientific discussion Tevaltan comp. Film-coated tablets 80 mg/12.5 mg and 160 mg/25 mg Valsartan and hydrochlorothiazide DK/H/1524/001-002/DC This module reflects the scientific
More informationCODEX STANDARD FOR EDIBLE CASEIN PRODUCTS
CODEX STAN A-18-1995, Rev. 1-2001 Page 1 of 5 CODEX STANDARD FOR EDIBLE CASEIN PRODUCTS CODEX STAN A-18-1995, Rev. 1-2001 The Annex to this Standard contains provisions which are not intended to be applied
More informationCODEX STANDARD FOR EDIBLE CASEIN PRODUCTS
CODEX STANDARD FOR EDIBLE CASEIN PRODUCTS CODEX STAN 290-1995 1. SCOPE This Standard applies to edible acid casein, edible rennet casein and edible caseinate, intended for direct consumption or further
More informationChange to read: BRIEFING
BRIEFING Dibasic Calcium Phosphate Dihydrate, USP 29 page 359. The Japanese Pharmacopoeia is the coordinating pharmacopeia for the international harmonization of the compendial standards for the Dibasic
More informationSTANDARD FOR EDIBLE CASEIN PRODUCTS CODEX STAN
STANDARD FOR EDIBLE CASEIN PRODUCTS CODEX STAN 290-1995 Formerly CODEX STAN A-18-1995. Adopted in 1995. Revision: 2001. Amendment: 2010, 2013, 2014, 2016. CODEX STAN 290-1995 2 1. SCOPE This Standard applies
More informationOpportunities for Zinc Compound Recovery from Mining Influenced Water
Opportunities for Zinc Compound Recovery from Mining Influenced Water Linda Figueroa 1, Kathleen Whysner 2 1 Colorado School of Mines, 1500 Illinois Street, Golden, Colorado 80401, USA, lfiguero@mines.edu
More informationThe Amendment of Standards for Specification, Scope, Application and Limitation of Food Additives
G/SPS/N/TPKM/136Add1 G/SPS/N/TPKM/139Add1 The Amendment of Standards for Specification, Scope, Application and Limitation of Food Additives DOH Food No. 0980400197, January 22, 2009 Appendix 1: Standards
More informationCODEX STANDARD FOR MILK POWDERS AND CREAM POWDER
CODEX STANDARD FOR MILK POWDERS AND CREAM POWDER CODEX STAN 207-1999 1. SCOPE This Standard applies to milk s and cream, intended for direct consumption or further processing, in conformity with the description
More informationPublic Assessment Report Scientific discussion. Rosuvastatin/Amlodipine 10 mg/5 mg, 10 mg/10 mg, 20 mg/5 mg and 20 mg/10 mg film-coated tablets
Public Assessment Report Scientific discussion Rosuvastatin/Amlodipine 10 mg/5 mg, 10 mg/10 mg, 20 mg/5 mg and 20 mg/10 mg film-coated tablets (Rosuvastatin calcium and Amlodipine besilate) ES/H/0320/001-004/DC
More informationPublic Assessment Report. Scientific discussion. Sumatriptan Actavis (sumatriptan succinate) SE/H/700/01-02/MR
Public Assessment Report Scientific discussion Sumatriptan Actavis (sumatriptan succinate) SE/H/700/01-02/MR This module reflects the scientific discussion for the approval of Sumatriptan Actavis, The
More informationSCIENTIFIC DISCUSSION
This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1
More information232 ELEMENTAL IMPURITIES LIMITS
BRIEFING 232 Elemental Impurities Limits, USP 39 page 268. This chapter is being revised to address comments received and to further align this chapter with ICH Q3D. USP s Elemental Impurities Expert Panel
More informationEdible casein products Specification
ICS 67.100.10 DMS 1396:2016 First edition CODEX STAN 290:1995 IDT DRAFT MALAWI STANDARD Edible casein products Specification NOTE: This is a draft proposal and it shall neither be used nor regarded as
More informationSTANDARD FOR MILK POWDERS AND CREAM POWDER CODEX STAN
STANDARD FOR MILK POWDERS AND CREAM POWDER CODEX STAN 207-1999 This Standard replaced the Standard for Whole Milk Powder, Partly Skimmed Milk Powder and Skimmed Milk Powder (A-5-1971) and the Standard
More informationPublic Assessment Report Scientific discussion. Echinaforce Forte, tablet. Asp. No:
Public Assessment Report Scientific discussion Echinaforce Forte, tablet Echinacea purpurea (L.) Moench (purple coneflower) herba recens, dry extract (17-34:1) and Echinacea purpurea (L.) Moench (purple
More informationגדות תעשיות ביוכימיה בע"מ Gadot Biochemical Industries Ltd.
Description: GadoMag K is citrate based Magnesium compound, designed to supplement liquid food products conveniently with a readily absorbable form of Magnesium. Best suitable for soy and dairy products
More informationגדות תעשיות ביוכימיה בע"מ Gadot Biochemical Industries Ltd.
Description: Citric Acid is a widely used and environment-friendly acidulant. The acid is manufactured by a submerged fermentation process, using various natural carbohydrates as substrates. General Characteristics:
More informationI International Bureau (10) International Publication Number (43) International Publication Date
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International
More informationUSP Excipients Standards Setting Process
USP Stakeholder Forum, Meeting #1 June 7, 2013 USP Excipients Standards Setting Process Catherine M. Sheehan, M.S., M.S. Sr. Director, Excipients US P Convention cxs@usp.org Historical Background on the
More informationOLIN CORPORATION SALES SPECIFICATION
PAGE 1 Date Printed: 2015-11-06 Supersedes Date: 09/29/2015 Previous Specified Material: 00008439 Additional Product Information: Clear, Viscous, Hygroscopic Liquid Shelf Life Container Type Conditions
More informationMONOGRAPHS (USP) Saccharin Sodium
Vol. 31(4) [July Aug. 2005] HARMONIZATION 1225 MONOGRAPHS (USP) BRIEFING Saccharin Sodium, USP 28 page 1745 and page 612 of PF 31(2) [Mar. Apr. 2005]. The United States Pharmacopeia is the coordinating
More informationEVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON DISINTEGRATION TEST GENERAL CHAPTER Q4B ANNEX 5(R1)
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
More informationגדות תעשיות ביוכימיה בע"מ Gadot Biochemical Industries Ltd.
Description: White hygroscopic odorless crystals having a sweet taste. General Characteristics: Formula: C 6 H 12 O 6 Molecular weight: 180 Appearance: White crystals Taste: Sweet Odor: Odorless Solubility
More informationSCIENTIFIC DISCUSSION
This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1
More informationPublic Assessment Report. Scientific discussion. Rispalan film-coated tablets Risperidone SE/H/685/01-07/MR
Public Assessment Report Scientific discussion Rispalan film-coated tablets Risperidone SE/H/685/01-07/MR This module reflects the scientific discussion for the approval of Rispalan film-coated tablets.
More informationBioequivalence Requirements: USA and EU
Bioequivalence Requirements: USA and EU Dr. Nicholas Cappuccino Chair, IGPA Science Committee Global Head of Quality, Dr. Reddy s Laboratories Ltd. 15 th Annual IGPA Conference Kyoto, Japan December 6,
More informationProduct Stewardship Information Sheet CH350LN
Product Stewardship Information Sheet CH350LN Contents Product Manufacturer... 2 Food Contact... 2 European Union (EU) Food Contact... 2 US Food and Drug Administration (FDA)... 2 Canada Health Protection
More informationCOMMISSION STAFF WORKING DOCUMENT 1. Review report for the active substance Copper compounds
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Directorate E Safety of the food chain Unit E.3 - Chemicals, contaminants, pesticides COMMISSION STAFF WORKING DOCUMENT 1 Review report for
More information» Monohydrate Citric Acid contains one molecule of water of hydration. It contains not less than 99.5 percent and not more than 100.
BRIEFING Citric Acid, Monohydrate. The European Pharmacopoeia is the coordinating pharmacopeia for the international harmonization of the compendial standards for the Citric Acid, Monohydrate monograph,
More informationSTANDARD FOR A BLEND OF SKIMMED MILK AND VEGETABLE FAT IN POWDERED FORM CODEX STAN Adopted in Amendment: 2010, 2013, 2014, 2016.
STANDARD FOR A BLEND OF SKIMMED MILK AND VEGETABLE FAT IN POWDERED FORM CODEX STAN 251-2006 Adopted in 2006. Amendment: 2010, 2013, 2014, 2016.. CODEX STAN 251-2006 2 1. SCOPE This Standard applies to
More informationSCIENTIFIC DISCUSSION
SCIENTIFIC DISCUSSION Name of the Finished Pharmaceutical Product: Manufacturer of Prequalified Product: Active Pharmaceutical Ingredients (APIs): Rifampicin/Isoniazid 150mg/75mg filmcoated Tablets Svizera
More informationPublic Assessment Report. Scientific discussion. Rabeprazolnatrium Torrent Pharma. 10 mg and 20 mg gastro-resistant tablets. Rabeprazole sodium
Public Assessment Report Scientific discussion Rabeprazolnatrium Torrent Pharma 10 mg and 20 mg gastro-resistant tablets Rabeprazole sodium DK/H/1819/001-002/DC This module reflects the scientific discussion
More informationSCIENTIFIC DISCUSSION. AkuriT-3 Tablets*
SCIENTIFIC DISCUSSION Name of the Finished Pharmaceutical Product: Manufacturer of Prequalified Product: Active Pharmaceutical Ingredients (APIs): Pharmaco-therapeutic group (ATC Code): Therapeutic indication:
More informationPublic Assessment Report. Scientific discussion. Carvedilol Aurobindo 6.25 mg and 25 mg, film-coated tablets (carvedilol) NL/H/2609/ /MR
Public Assessment Report Scientific discussion Carvedilol Aurobindo 6.25 mg and 25 mg, film-coated tablets (carvedilol) NL/H/2609/001-002/MR Date: 26 May 2014 This module reflects the scientific discussion
More informationPublic Assessment Report Scientific discussion
Public Assessment Report Scientific discussion Sertralin Actavis (Sertralpharm) Sertraxea Tifisertral Sertraparma Applicant: Alfred E. Tiefenbacher (GmbH & Co.) Hamburg, Germany Ziral Applicant: A.V.I.
More informationProduct Stewardship Information Sheet CH200LN-02
Product Stewardship Information Sheet CH200LN-02 Contents Product Manufacturer... 2 Food Contact... 2 European Union (EU) Food Contact... 2 US Food and Drug Administration (FDA)... 2 Canada Health Protection
More informationSCIENTIFIC DISCUSSION
SCIENTIFIC DISCUSSION 1 Introduction This is an application for a CHMP Scientific Opinion in accordance with Article 58 of Regulation (EC) No 726/2004, in the context of cooperation with the World Health
More informationUnited Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE
United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT Forthyron
More informationPublic Assessment Report. Scientific discussion. Tadalafil 1A Pharma 2.5 mg, 5 mg, 10 mg and 20 mg, film-coated tablets.
Public Assessment Report Scientific discussion Tadalafil 1A Pharma 2.5 mg, 5 mg, 10 mg and 20 mg, film-coated tablets (tadalafil) NL/H/3634/001-004/DC Date: 24 May 2017 This module reflects the scientific
More informationEUROPEAN COMMISSION DG Employment, Social Affairs and Inclusion. The Advisory Committee on Safety and Health at Work. Opinion
EUROPEAN COMMISSION DG Employment, Social Affairs and Inclusion Employment and Social Legislation, Social Dialogue Health, Safety and Hygiene at Work Doc.1893-EN The Advisory Committee on Safety and Health
More informationMEDICNES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF HERBAL MEDICINAL PRODUCTS IN THE GAMBIA
MEDICNES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF HERBAL MEDICINAL PRODUCTS IN THE GAMBIA Document No.: MCA/HMPG/17/12/01 Date of Adoption: 20 th January 2017 Date of Issue: 25 th July 2017 Version
More informationGCC STANDARDIZATION ORGANIZATION (GSO)
ھيئة التقييس لدول مجلس التعاون لدول الخليج العربية GCC STANDARDIZATION ORGANIZATION (GSO) GSO/FDS 194 /2014 طحين ) دقيق ( القمح WHEAT FLOUR Prepared by: Gulf technical committee for food and agricultural
More informationTest Report. No. CANEC Date: 27 May Page 1 of 9. (SVHC)
Test Report. No. CANEC1709420105 Date: 27 May 2017. Page 1 of 9. FOSHAN NAN HAI SHOUAN ALLOY MATERIAL CO.,LTD. NO.9, FRONT ROW, HUA FA ELECTRICAL SQUARE, PING DI, YANBU, GUANGFO ROAD, NANHAI DISTRICT,
More informationDraft Indian Standard SODIUM HYDROXIDE, FOOD GRADE SPECIFICATION
Doc:FAD 8(1886)C Draft Indian Standard SODIUM HYDROXIDE, FOOD GRADE SPECIFICATION Not to be reproduced without the permission of BIS or used as a Standard Last date for receipt of comments is 2008 05 15
More informationSummary Public Assessment Report. Generics. Fluoxetina Aurobindo PT/H/1137/ /DC. Date:
Summary Public Assessment Report Generics 20 mg, 60mg Capsules, hard (fluoxetine hydrochloride) PT/H/1137/001-002/DC Date: 11-11-2014 1/7 Summary Public Assessment Report Generics Fluoxetin hydrochloride,
More informationInternational Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
Final Concept Paper E9(R1): Addendum to Statistical Principles for Clinical Trials on Choosing Appropriate Estimands and Defining Sensitivity Analyses in Clinical Trials dated 22 October 2014 Endorsed
More informationBRIEFING. Nonharmonized attributes: Identification, Heavy metals, Characters, Labeling, Bacterial endotoxins, Sterility, Storage.
BRIEFING Citric Acid, Anhydrous, page 872 of PF 28(3) [May June 2002]. The European Pharmacopoeia is the coordinating pharmacopeia for the international harmonization of the compendial standards for the
More informationFLORITER. New Technology for Innovative Formulation Design.
FLORITER New Technology for Innovative Formulation Design www.tomitaph.co.jp FLORITE Dramatically Change Your Formulation FLORITE is synthetic Calcium Silicate with exceptional liquid absorbency and excellent
More informationOrganic Impurities in Drug Substances and Drug Products. Antonio Hernandez-Cardoso, M.Sc. Senior Scientific Liaison September 8, 2017
Organic Impurities in Drug Substances and Drug Products Antonio Hernandez-Cardoso, M.Sc. Senior Scientific Liaison September 8, 2017 Potential sources of drug impurities during development AAPS PharmSciTech,
More informationPublic Assessment Report Scientific discussion. Anastrozole Bluefish 1 mg film-coated tablets (anastrozole) SE/H/781/01/DC
Public Assessment Report Scientific discussion Anastrozole Bluefish 1 mg film-coated tablets (anastrozole) SE/H/781/01/DC This module reflects the scientific discussion for the approval of Anastrozole
More informationASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS)
Association of South East Asian Nations (ASEAN) ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS) Version 3.0 CONTENTS 1. Introduction...2 2. Objective...
More informationPART I : List of documents
EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate D - Food Safety: production and distribution chain D1 Animal nutrition PART I : List of documents A. Basic documents SCFCAH-SAN/04-2003
More informationNew Annex 15 Updated Requirements & Approach to Validation. Presented by Ashley Isbel 10 th August 2015
New Annex 15 Updated Requirements & Approach to Validation Presented by Ashley Isbel 10 th August 2015 EU GMP Guide Annex 15 Qualification & Validation 2001 Current version of Annex 15 published Nov 2012
More informationPublic Assessment Report Scientific discussion. Rizatriptan Orifarm (rizatriptan) SE/H/1104/01-02/DC
Public Assessment Report Scientific discussion Rizatriptan Orifarm (rizatriptan) SE/H/1104/01-02/DC This module reflects the scientific discussion for the approval of Rizatriptan Orifarm. The procedure
More informationFormulations: PIPs evaluation-case studies
Formulations: PIPs evaluation-case studies Viewpoint from the EMA - Quality team EMA/EFPIA Info day 2011 23 May 2011 Presented by: Caroline Le Barbier, PhD & Isabel Esteve Scientific Administrators/Chemicals/Biologicals/Quality
More informationICH guideline Q3D (R1) on elemental impurities
1 2 3 16 May2018 EMA/CHMP/ICH/353369/2013 Committee for Human Medicinal Products 4 5 Step 2b 6 Transmission to CHMP 26 April 2018 Adoption by CHMP for release for consultation 26 April 2018 Start of consultation
More informationQ2. What categories of production aids can be used in manufacturing paper pulp?
Q&A of the 4 th Food Contact Material Safety Forum With the publication of new Chinese FCM national safety regulations, the focus of this forum is to discuss the possible impacts on both the surveillance
More informationגדות תעשיות ביוכימיה בע"מ Gadot Biochemical Industries Ltd.
General Characteristics: Formula: Ca 3(C6H5O7(2 *4H2O Molecular weight: 570.6 Appearance: Fine white free flowing powder Odor: Odorless Solubility: In water - Almost insoluble In alcohol - Insoluble CAS
More informationBottom Ash Data Week 30
Bottom Ash Data 2018 Week 30 The following analytical report was sent to the Ministry of Environment and Climate Change Strategy on August 14, 2018. The data represents bottom ash composite results for
More informationBottom Ash Data Week 38
Bottom Ash Data 2018 Week 38 The following analytical report was sent to the Ministry of Environment and Climate Change Strategy on October 4, 2018. The data represents bottom ash composite results for
More informationAppendix D: Aerobic and Anaerobic Leaching Tests
Appendix D: Aerobic and Anaerobic Leaching Tests This appendix contains the entire data set for the aerobic and anaerobic testing. Testing was performed for the potential components of the final media
More informationBottom Ash Data Week 8
Bottom Ash Data 2019 Week 8 The following analytical report was sent to the Ministry of Environment and Climate Change Strategy on March 6, 2019. The data represents bottom ash composite results for week
More informationThe ICHS1 Regulatory Testing Paradigm of Carcinogenicity in rats - Status Report
INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE The ICHS1 Regulatory Testing Paradigm of Carcinogenicity in rats - Status Report Introduction The ICH
More informationSCIENTIFIC DISCUSSION. Lopinavir and Ritonavir 200 mg/50 mg Tablets * Name of the Finished Pharmaceutical Product:
SCIENTIFIC DISCUSSION Name of the Finished Pharmaceutical Product: Manufacturer of Prequalified Product: Active Pharmaceutical Ingredients (APIs): Pharmaco-therapeutic group (ATC Code): Therapeutic indication:
More informationBottom Ash Data Week 40
Bottom Ash Data 2018 Week 40 The following analytical report was sent to the Ministry of Environment and Climate Change Strategy on October 25, 2018. The data represents bottom ash composite results for
More informationBottom Ash Data Week 12
Bottom Ash Data 2019 Week 12 The following analytical report was sent to the Ministry of Environment and Climate Change Strategy on April 11, 2019. The data represents bottom ash composite results for
More informationDr. Christian Zeine LGC Standards GmbH. Webinar Series 2013 July 2013
The 7 truths of impurities and their reference standards FDA's and other regulators' viewpoints and further stories (Part 1) Dr. Christian Zeine LGC Standards GmbH Webinar Series 2013 July 2013 Quick guide
More informationBottom Ash Data Week 49
Bottom Ash Data 2018 Week 49 The following analytical report was sent to the Ministry of Environment and Climate Change Strategy on December 20, 2018. The data represents bottom ash composite results for
More information